Stay updated with breaking news from Lexaria Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Invenomic Capital Management LP raised its stake in Lexaria Bioscience Corp. (NASDAQ:LEXX – Free Report) by 62.0% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 766,573 shares of the company’s stock after buying an additional 293,470 shares during the quarter. Invenomic Capital Management LP owned approximately 9.48% […]
07.12.2023 - KELOWNA, BC / ACCESSWIRE / December 7, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the 'Company' or 'Lexaria'), a global innovator in drug delivery platforms, announces that the Company's anticipated submission of an Investigational ... Seite 1
LEXARIA BIOSCIENCE CORP. NASDAQ: LEXX INVESTOR CONTACT Phone: 250-765-6424 ext. 202...
LEXARIA BIOSCIENCE CORP. NASDAQ: LEXX INVESTOR CONTACT Phone: 250-765-6424 ext. 202...